Sclerosis News and Research

RSS

Drug for multiple sclerosis prevented disease development when tested on animal models

Scientists from the Neurological Sciences Institute at Oregon Health & Science University have shown that an investigative drug for multiple sclerosis and related diseases prevented disease development when tested on animal models.

20 Jun 2004

Support for the medical use of marijuana

Manhattan District Attorney Robert M. Morgenthau has announced his support for the medical use of marijuana. The District Attorney was joined by Montel Williams in announcing support for legislation introduced by New York State Assemblyman Richard Gottfried.

16 Jun 2004

74 percent of Americans support call for the Bush White House to lift restrictions on stem cell research

By a decisive margin of 74-21 percent, Americans support former First Lady Nancy Reagan’s call for the Bush White House to lift restrictions on stem cell research in order to look for possible treatments for the Alzheimer’s disease that afflicted former President Ronald Reagan prior to his recent death

16 Jun 2004

Results from study of Rituxan in rheumatoid arthritis show promise

Genentech, Inc., Biogen Idec and Roche have announced that the New England Journal of Medicine published the results of a Phase IIa study showing that two doses of Rituxan® (Rituximab), administered two weeks apart, improved symptoms in patients with moderate-to-severe rheumatoid arthritis (RA) for up to 48 weeks when combined with methotrexate (MTX), compared to MTX alone.

16 Jun 2004

Significant vaccine advance for Parkinson’s disease therapy

Scientists at the University of Nebraska Medical Center in Omaha and Columbia University Medical Center in New York have discovered a new vaccine approach that successfully prevents the death of brain cells in a mouse model of Parkinson’s disease.

15 Jun 2004

Cannabis extract drug may help patients with rheumatoid arthritis

The multi centre double blind, randomised, parallel group study in 58 patients assessed the efficacy, safety and tolerability of Sativex®, a whole plant medicinal cannabis extract, compared with placebo for the treatment of pain caused by Rheumatoid Arthritis. Study medication was administered by means of a spray into the mouth as an evening dose only and measures were assessed the following day.

11 Jun 2004

Sirolimus-based therapy following early cyclosporine withdrawal improves transplanted kidney structure and function

Kidney histology and function three years after transplantation are better in kidney-transplant patients who remain on sirolimus-based therapy following early withdrawal of cyclosporine than in patients who continue on this calcineurin inhibitor, according to a new study published in the American Journal of Transplantation.

11 Jun 2004

Just six months of yoga significantly reduces fatigue in people with multiple sclerosis

Just six months of yoga significantly reduces fatigue in people with multiple sclerosis, but it has no effect on alertness and cognitive function, says a new Oregon Health & Science University study.

11 Jun 2004

Drug commonly used for diabetes might be effective in treating multiple sclerosis

Researchers at the University of Illinois at Chicago are launching a clinical trial to determine whether a drug commonly used for diabetes might be effective in treating multiple sclerosis, an autoimmune disease that affects 350,000 Americans.

10 Jun 2004

Epilepsy drugs can increase the rate of bone loss in older women

Epilepsy drugs can increase the rate of bone loss in older women, according to a study published in the June 8 issue of Neurology, the scientific journal of the American Academy of Neurology.

9 Jun 2004

Many epilepsy and multiple sclerosis patients believe marijuana is an effective treatment

Despite limited evidence of effectiveness, many epilepsy and multiple sclerosis patients believe marijuana is an effective treatment and are actively using it, according to two Canadian studies published in the June 8 issue of Neurology, the scientific journal of the American Academy of Neurology.

9 Jun 2004

Acne drug may help treat multiple sclerosis

Dr. Luanne Metz, an associate professor of neurosciences and physician-scientist in the Neuroscience Research Group at the University of Calgary’s Faculty of Medicine, has found that minocycline, a drug currently used to treat such conditions as acne, decreases the activity of lesions in the brains of people suffering from multiple sclerosis (MS).

2 Jun 2004

Researchers identify molecules that underlie nerve fiber degeneration in multiple sclerosis patients

Yale researchers and collaborators have identified molecules that underlie nerve fiber degeneration in patients with secondary progressive multiple sclerosis (MS), a disease that cripples nearly three million people worldwide. The new findings are the first observations in humans of molecules that contribute to degeneration of nerve fibers.

27 May 2004

30-ton superconducting magnet to further brain research

The 30-ton, superconducting magnet that forms the center of a 7-Tesla MRI (magnetic resonance imaging) system developed by Siemens Medical Solutions will be uncrated and moved by crane from a truck into the New York University School of Medicine’s Center for Biomedical Imaging this Friday morning.

26 May 2004

Possible new second-generation multiple sclerosis therapy

Scientists from Genencor International, Inc., have demonstrated in an in vivo model that a new variant of recombinant interferon-beta reduces the immunological response to the protein.

25 May 2004

A new guideline evaluates the treatment of infantile spasms

A new guideline developed by the American Academy of Neurology and the Child Neurology Society evaluates the treatment of infantile spasms. The guideline is published in the May 25 issue of Neurology, the scientific journal of the American Academy of Neurology.

24 May 2004

People with low incomes are more likely to develop brain cancer

People with low incomes are more likely to develop brain cancer, according to a study published in the May 25 issue of Neurology, the scientific journal of the American Academy of Neurology.

24 May 2004

Trial shows Daclizumab therapy improves multiple sclerosis outcome

A small clinical trial of patients with multiple sclerosis (MS) who did not respond to interferon alone found that adding the human antibody daclizumab improved patient outcome. Patients who received the combined therapy had a 78 percent reduction in new brain lesions and a 70 percent reduction in total lesions, along with other significant clinical improvements.

24 May 2004

New book highlights pros and cons of medical use of cannabis

A new book which brings together the relevant science regarding the beneficial effects of cannabis for identified medical conditions and explains many harmful side effects has been launched at Australia's Southern Cross University today.

19 May 2004

$1.4 million to investigate how strokes and other events that cut off blood flow to the brain disrupt the blood-brain barrier

The Cleveland Clinic has been awarded a four-year, $1.4 million grant from the National Institutes of Health to investigate how strokes and other events that cut off blood flow to the brain disrupt the blood-brain barrier. Researchers hope to use their findings to develop new methods to limit the damage caused by such events.

17 May 2004

Sclerosis News and Research

Drug for multiple sclerosis prevented disease development when tested on animal models

Support for the medical use of marijuana

74 percent of Americans support call for the Bush White House to lift restrictions on stem cell research

Results from study of Rituxan in rheumatoid arthritis show promise

Significant vaccine advance for Parkinson’s disease therapy

Cannabis extract drug may help patients with rheumatoid arthritis

Sirolimus-based therapy following early cyclosporine withdrawal improves transplanted kidney structure and function

Just six months of yoga significantly reduces fatigue in people with multiple sclerosis

Drug commonly used for diabetes might be effective in treating multiple sclerosis

Epilepsy drugs can increase the rate of bone loss in older women

Many epilepsy and multiple sclerosis patients believe marijuana is an effective treatment

Acne drug may help treat multiple sclerosis

Researchers identify molecules that underlie nerve fiber degeneration in multiple sclerosis patients

30-ton superconducting magnet to further brain research

Possible new second-generation multiple sclerosis therapy

A new guideline evaluates the treatment of infantile spasms

People with low incomes are more likely to develop brain cancer

Trial shows Daclizumab therapy improves multiple sclerosis outcome

New book highlights pros and cons of medical use of cannabis

$1.4 million to investigate how strokes and other events that cut off blood flow to the brain disrupt the blood-brain barrier

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News